title: Fatal invasive aspergillosis of the larynx.
authors.affiliation: Department of Haematology, The Christie NHS Foundation Trust, Manchester, UK.
authors.forename: Mark S
authors.initials: MS
authors.lastname: Williams
authors.forename: Nisha
authors.initials: N
authors.lastname: Ali
authors.forename: Daisuke
authors.initials: D
authors.lastname: Nonaka
authors.forename: Adrian J
authors.initials: AJ
authors.lastname: Bloor
authors.forename: Tim C P
authors.initials: TC
authors.lastname: Somervaille
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects; D001215:Asparaginase / Q000009:adverse effects; D001228:Aspergillosis / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology; D060830:Consolidation Chemotherapy / Q000009:adverse effects; D003630:Daunorubicin / Q000009:adverse effects; D017809:Fatal Outcome; D006801:Humans; D007818:Laryngeal Diseases / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000209:etiology; D008297:Male; D009894:Opportunistic Infections / Q000175:diagnosis / Q000209:etiology; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications / Q000188:drug therapy; D011241:Prednisone / Q000009:adverse effects; D014057:Tomography, X-Ray Computed; D014750:Vincristine / Q000009:adverse effects; D055815:Young Adult
chemical_list: D014750:Vincristine; D001215:Asparaginase; D011241:Prednisone; D003630:Daunorubicin